Yuyu Pharma Inc Cash Flow Quality Index

Latest as of June 2026: 1.35x

Yuyu Pharma Inc cash flow quality index. Yuyu Pharma Inc (000225) has a Cash Flow Quality Index of 1.35x as of June 2026. Operating cash flow of ₩4.91 Billion exceeds net income of ₩3.65 Billion, indicating high earnings quality where cash backs reported profits. See 000225 FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.

Cash Flow Quality Index

1.35x
Operating CF / Net Income

Operating Cash Flow

₩4.91 Billion
KRW

Net Income

₩3.65 Billion
KRW

Data as of

Jun 2026
Most recent filing

Cash Flow Quality Index of Yuyu Pharma Inc (2016–2025)

Cash flow quality index of Yuyu Pharma Inc from 2016 to 2025. Historical Cash Flow Quality Index for Yuyu Pharma Inc across 7 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore Yuyu Pharma Inc cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.

Yuyu Pharma Inc Cash Flow Quality Index by Year (2016–2025)

Yuyu Pharma Inc cash flow quality index by year from 2016 to 2025. Year-by-year earnings quality comparison for Yuyu Pharma Inc. For the full cash flow conversion analysis, see Yuyu Pharma Inc (000225) cash conversion ratio.

Year Quality Index Operating CF (KRW) Net Income YoY Change
2025 1.95x ₩15.88 Billion ₩8.15 Billion ▼ -31.9%
2024 2.86x ₩24.95 Billion ₩8.72 Billion ▲ +237.6%
2020 -2.08x ₩-2.67 Billion ₩1.28 Billion ▼ -174.5%
2019 2.79x ₩13.19 Billion ₩4.72 Billion ▲ +83.7%
2018 1.52x ₩6.11 Billion ₩4.02 Billion ▲ +1584.3%
2017 0.09x ₩561.35 Million ₩6.22 Billion ▼ -94.6%
2016 1.67x ₩9.82 Billion ₩5.89 Billion —
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.